Benchmark Reiterates Speculative Buy Rating for Movano (NASDAQ:MOVE)

Movano (NASDAQ:MOVE)‘s stock had its “speculative buy” rating restated by analysts at Benchmark in a report released on Wednesday, Benzinga reports. They presently have a $2.00 target price on the technology company’s stock.

Movano Price Performance

NASDAQ:MOVE opened at $0.30 on Wednesday. The firm has a 50-day moving average of $0.35 and a 200-day moving average of $0.42. The company has a market cap of $29.58 million, a PE ratio of -0.54 and a beta of 0.12. Movano has a one year low of $0.24 and a one year high of $1.25.

Institutional Investors Weigh In On Movano

Several hedge funds and other institutional investors have recently made changes to their positions in MOVE. Quantum Private Wealth LLC increased its position in shares of Movano by 113.8% during the second quarter. Quantum Private Wealth LLC now owns 89,139 shares of the technology company’s stock worth $25,000 after acquiring an additional 47,441 shares in the last quarter. EP Wealth Advisors LLC purchased a new position in Movano during the fourth quarter worth about $101,000. Mirador Capital Partners LP boosted its holdings in Movano by 9.6% during the first quarter. Mirador Capital Partners LP now owns 413,204 shares of the technology company’s stock worth $170,000 after purchasing an additional 36,230 shares during the last quarter. Finally, Dorsey & Whitney Trust CO LLC boosted its holdings in Movano by 50.0% during the second quarter. Dorsey & Whitney Trust CO LLC now owns 5,630,084 shares of the technology company’s stock worth $1,548,000 after purchasing an additional 1,876,000 shares during the last quarter. 16.64% of the stock is owned by institutional investors.

About Movano

Movano Inc engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.